Literature DB >> 16893905

Allelic mRNA expression of X-linked monoamine oxidase a (MAOA) in human brain: dissection of epigenetic and genetic factors.

Julia K Pinsonneault1, Audrey C Papp, Wolfgang Sadée.   

Abstract

A pVNTR repeat polymorphism located in the promoter region of the X-linked MAOA gene has been associated with mental disorders. To explore the effect of polymorphisms and epigenetic factors on mRNA expression, we have measured allelic expression imbalance (AEI) in female human brain tissue, employing two frequent marker single nucleotide polymorphisms (SNPs) in exon 8 (T890G) and exon 14 (C1409T) of MAOA. This approach compares one allele against the other in the same subject. AEI ratios ranged from 0.3 to 4 in prefrontal cortex, demonstrating the presence of strong cis-acting factors in mRNA expression. Analysis of CpG methylation in the MAOA promoter region revealed substantial methylation in females but not in males. MAOA methylation ratios for the three- and four-repeat pVNTR alleles of MAOA did not correlate with X-chromosome inactivation ratios, determined at the X-linked androgen receptor locus, suggesting an alternative process of dosage compensation in females. The extent of allelic MAOA methylation was highly variable and correlated with AEI (R2=0.5 and 0.7 at two CpG loci), indicating that CpG methylation regulates gene expression. Genetic factors appeared also to contribute to the AEI ratios. Genotyping of 13 MAOA polymorphisms in female subjects showed strong association with a haplotype block spanning from the pVNTR to the marker SNP. Therefore, allelic mRNA expression is affected by genetic and epigenetic events, both with the potential to modulate biogenic amine tone in the CNS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893905     DOI: 10.1093/hmg/ddl192

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  43 in total

1.  Identification and characterization of putative methylation targets in the MAOA locus using bioinformatic approaches.

Authors:  Elena Shumay; Joanna S Fowler
Journal:  Epigenetics       Date:  2010-05-05       Impact factor: 4.528

2.  A longitudinal study of epigenetic variation in twins.

Authors:  Chloe Chung Yi Wong; Avshalom Caspi; Benjamin Williams; Ian W Craig; Renate Houts; Antony Ambler; Terrie E Moffitt; Jonathan Mill
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

Review 3.  Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy.

Authors:  W Sadee; D Wang; A C Papp; J K Pinsonneault; R M Smith; R A Moyer; A D Johnson
Journal:  Clin Pharmacol Ther       Date:  2011-02-02       Impact factor: 6.875

Review 4.  Genetics of human aggressive behaviour.

Authors:  Ian W Craig; Kelly E Halton
Journal:  Hum Genet       Date:  2009-06-09       Impact factor: 4.132

5.  Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.

Authors:  Andrew D Johnson; Ying Zhang; Audrey C Papp; Julia K Pinsonneault; Jeong-Eun Lim; David Saffen; Zunyan Dai; Danxin Wang; Wolfgang Sadée
Journal:  Pharmacogenet Genomics       Date:  2008-09       Impact factor: 2.089

6.  No evidence for association between an MAOA functional polymorphism and susceptibility to Parkinson's disease.

Authors:  Caroline Williams-Gray; An Goris; Thomas Foltynie; Alastair Compston; Stephen Sawcer; Roger A Barker
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

Review 7.  Epigenetic signature of MAOA and MAOB genes in mental disorders.

Authors:  Christiane Ziegler; Katharina Domschke
Journal:  J Neural Transm (Vienna)       Date:  2018-09-21       Impact factor: 3.575

8.  Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response.

Authors:  Katharina Domschke; Nicola Tidow; Kathrin Schwarte; Christiane Ziegler; Klaus-Peter Lesch; Jürgen Deckert; Volker Arolt; Peter Zwanzger; Bernhard T Baune
Journal:  J Neural Transm (Vienna)       Date:  2014-05-10       Impact factor: 3.575

9.  Transcription factor AP-2 beta genotype and psychosocial adversity in relation to adolescent depressive symptomatology.

Authors:  Kent W Nilsson; Rickard L Sjöberg; Jerzy Leppert; Lars Oreland; Mattias Damberg
Journal:  J Neural Transm (Vienna)       Date:  2009-01-28       Impact factor: 3.575

10.  Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.

Authors:  Alessandro Bertolino; Leonardo Fazio; Grazia Caforio; Giuseppe Blasi; Antonio Rampino; Raffaella Romano; Annabella Di Giorgio; Paolo Taurisano; Audrey Papp; Julia Pinsonneault; Danxin Wang; Marcello Nardini; Teresa Popolizio; Wolfgang Sadee
Journal:  Brain       Date:  2008-10-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.